SPROGØE, Kennett,RAU, Harald,BERNHARD, Ana,HERSEL, Ulrich,CLEEMANN, Felix,WEGGE, Thomas
申请号：
HK19101752
公开号：
HK1259384A1
申请日:
2019.01.31
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention relates to controlled-release CNP agonists having an at least 5-fold longer degradation half-life in an in vitro NEP degradation assay than the corresponding released CNP agonist, to pharmaceutical compositions comprising said controlled-release CNP agonist, their use and to methods of treatment.
